Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Trump, first lady set for Washington Trump–Kennedy Center...
Trump-Kennedy Center blasts ‘far-left bias’ in ratings coverage,...
Senate Republicans eye reconciliation to address Minnesota fraud...
BROOKE ROLLINS, ROBERT KENNEDY JR: New dietary plan...
5 GOP senators join Democrats to stop Trump...
Senate Dem John Fetterman supports prospect of US...
Vance calls Walz ‘a joke,’ claims Minnesota governor...
JD Vance announces multi-state fraud task force in...
Trump calls for $1.5T defense budget to build...
Trump blasts GOP war powers defectors, says they...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Former Biden doctor asks to delay testimony to House committee investigating mental fitness

by admin July 8, 2025
July 8, 2025
Former Biden doctor asks to delay testimony to House committee investigating mental fitness

Former White House physician Kevin O’Connor, who served as doctor to former President Joe Biden, requested a delay to his upcoming testimony before the House Oversight Committee this week.

O’Connor was scheduled to testify on Wednesday, but is now in a disagreement with the committee over the scope of the questions he will be expected to answer during his testimony. The committee, led by Chairman James Comer, R-Ky., is interviewing the doctor as part of its investigation into Biden’s mental fitness and his administration’s use of an autopen.

A lawyer for O’Connor requested the testimony be delayed to July 28 or August 4 in a letter to Comer.

‘Dr. O’Connor has legal and ethical obligations that he must satisfy and for which violations carry serious consequences to him professionally and personally,’ the letter says.

‘We are unaware of any prior occasion on which a Congressional Committee has subpoenaed a physician to testify about the treatment of an individual patient.  And the notion that a Congressional Committee would do so without any regard whatsoever for the confidentiality of the physician-patient relationship is alarming.’

A spokesman for the Oversight Committee replied in a statement that O’Connor and his legal team were merely trying to ‘stonewall’ the process. The committee is planning to move forward with Wednesday’s testimony, which O’Connor faces a subpoena to attend.

The committee said O’Connor is welcome to object to individual questions during his testimony. But O’Connor is not allowed, in the committee’s view, to delay or decline a congressional subpoena due to concerns over questions about potentially privileged information.

The debate over O’Connor’s testimony comes weeks after a former top aide to Biden, Neera Tanden, told the Oversight Committee that she was authorized to direct autopen signatures but was unaware of who in the president’s inner circle was giving her final clearance.

During Tanden’s interview before Congress last month, which lasted more than five hours, she told lawmakers that, in her role as staff secretary and senior advisor to the former president between 2021 and 2023, she was authorized to direct autopen signatures on behalf of Biden, an Oversight Committee official told Fox News.

‘Ms. Tanden testified that she had minimal interaction with President Biden, despite wielding tremendous authority,’ Comer said at the time. ‘She explained that to obtain approval for autopen signatures, she would send decision memos to members of the President’s inner circle and had no visibility of what occurred between sending the memo and receiving it back with approval. Her testimony raises serious questions about who was really calling the shots in the Biden White House amid the President’s obvious decline. We will continue to pursue the truth for the American people.’

Fox News’ Kelly Phares and Madeleine Rivera and the Associated Press contributed to this report.

This post appeared first on FOX NEWS

previous post
New book exposes Jill Biden’s power grab amid husband’s political demise
next post
Key advisor called Hunter Biden’s role on strategy call ‘inappropriate’ after he overruled legal guidance

You may also like

Biden’s ex-chief of staff arrives for House Oversight...

September 18, 2025

Senate GOP resists ‘nuclear option’ as Dem shutdown...

October 9, 2025

New report warns of growing national security threat...

December 22, 2024

WH maintains Trump consistent in firm stance on...

June 18, 2025

Trump’s historic Abraham Accords would be bolstered with...

September 16, 2024

Harris’ impact on race with Trump revealed in...

July 23, 2024

Hillary Clinton fires up voters against Trump’s White...

October 21, 2025

Trump flips his shutdown approach, leaving Congress to...

October 6, 2025

Israel’s Minister of Defense cancels visit to Pentagon...

October 10, 2024

Here’s what Kash Patel’s former colleagues are saying...

December 6, 2024

Recent Posts

  • Trump, first lady set for Washington Trump–Kennedy Center premiere of ‘MELANIA’ ahead of global release
  • Trump-Kennedy Center blasts ‘far-left bias’ in ratings coverage, points to No. 1 demographics tie
  • Senate Republicans eye reconciliation to address Minnesota fraud scandal
  • BROOKE ROLLINS, ROBERT KENNEDY JR: New dietary plan recommends real food for all Americans
  • 5 GOP senators join Democrats to stop Trump from policing Venezuela

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (964)
    • Investing (3,824)
    • Politics (4,621)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.